Fate Therapeutics, Inc. · NASDAQ:FATE
Valamehr Bahram sold 43,947 Fate Therapeutics, Inc. shares (Form 4)
Traded Aug 4, 2026 · Filed Aug 5, 2026
On Aug 4, 2026, Valamehr Bahram (Director, President and CEO) sold 43,947 Fate Therapeutics, Inc. shares at US$2.46 for US$108K, leaving 591,815 shares. Filed Aug 5, 2026 (Form 4).
- Sold
- 43,947 shares
- Price
- US$2.46
- Value
- US$108K
- Holding after
- 591,815 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 4, 2026 | Common Stock | Sale | 43,947 | US$2.46 | 591,815 | Direct |